Najla H. El Jurdi

Hematology | Oncology

909 Fulton St SE
Minneapolis, MN 55455

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Plasma proteins associated with chronic graft-versus-host disease organ involvement.

Plasma proteins associated with chronic graft-versus-host disease organ involvement.

Journal: JCI insight

Published: July 28, 2026

Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

Journal: American journal of hematology

Published: May 18, 2026

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 30, 2026

Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study.

Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study.

Journal: Cancers

Published: April 22, 2026

Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host Disease.

Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host Disease.

Journal: JAMA dermatology

Published: January 21, 2026

Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.

Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.

Journal: Blood advances

Published: October 27, 2025

Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

Journal: Blood advances

Published: October 27, 2025

Obesity Associations with Chronic Graft-Versus-Host Disease.

Obesity Associations with Chronic Graft-Versus-Host Disease.

Journal: Transplantation and cellular therapy

Published: September 02, 2025

Sirolimus use in allogeneic hematopoietic cell transplant recipients: assessing its senotherapeutic role in a high risk population.

Sirolimus use in allogeneic hematopoietic cell transplant recipients: assessing its senotherapeutic role in a high risk population.

Journal: Frontiers in aging

Published: July 25, 2025

Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.

Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.

Journal: Transplantation

Published: June 23, 2025

Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study.

Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study.

Journal: Transplantation

Published: June 23, 2025

Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients.

Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients.

Journal: Blood advances

Published: June 17, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026